Latest News about Pharmaceuticals
Recent news which mentions Pharmaceuticals
From CNBC.com News
 From CNBC.com News
 From CNBC.com News
 
   Biogen Gives Up On Aduhelm Efforts After Two Years Of Controversial FDA Accelerated Approval For Alzheimer's, Shifts Focus On Newer Medicines
   
  
  
  January 31, 2024
  From Benzinga
 
   Biogen drops controversial Alzheimer's drug Aduhelm to focus on Leqembi, experimental treatments
   
  
  January 31, 2024
  From CNBC.com News
 
   GSK posts blowout RSV vaccine sales, raises outlook as shots give big pharma a boost
   
  
  January 31, 2024
  From CNBC.com News
 
   Norway's giant wealth fund touts possibility of Novo Nordisk, Eli Lilly joining the trillion-dollar club
   
  
  January 31, 2024
  From CNBC.com News
 
   Vertex non-opioid painkiller shows positive results in critical late-stage trial on acute pain
   
  
  January 30, 2024
  From CNBC.com News
 
   Pfizer beats earnings estimates as declining Covid business performs better than expected
   
  
  January 30, 2024
  From CNBC.com News
 
   Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs
   
  
  January 28, 2024
  From CNBC.com News
 
   Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug prices
   
  
  January 26, 2024
  From CNBC.com News
 
   Humana stock plunges on dismal 2024 forecast, as insurers face soaring medical costs
   
  
  January 25, 2024
  From CNBC.com News
 
   Johnson & Johnson to settle talc baby powder investigation, will reportedly pay $700 million
   
  
  January 23, 2024
  From CNBC.com News
 
   Johnson & Johnson narrowly tops quarterly estimates as pharmaceutical, medtech sales jump
   
  
  January 23, 2024
  From CNBC.com News
 
   Gilead stock falls after disappointing lung cancer study results
   
  
  January 22, 2024
  From CNBC.com News
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 


